SOURCE: Medical Care Technologies, Inc.

January 15, 2010 07:30 ET

Medical Care Technologies Inc. Enters Discussions to Launch Its First Telehealth Clinic in North China

LONDON--(Marketwire - January 15, 2010) - Medical Care Technologies Inc. (OTCBB: MDCE) today announced that the company has entered into discussions with Chinese local officials to launch MDCE's first Telehealth Clinic in North China. The Telehealth Clinic is planned to open in Tianjin, about 100 kilometers Southeast of Beijing, and will be the first of many that the company plans to open which will fully utilize MDCE's Telehealth technology.

MDCE is diligently working in conjunction with the local Tianjin authorities to assist in integrating itself into China's healthcare system at a grass roots level and to assist its mission to help China improve its much maligned health care systems. The move is also viewed as a vital source of income to MDCE.

Management plans to open Telehealth Clinic facilities in Tianjin and its surrounding areas which will offer family practice consultations, coordination and provision of prompt emergency evacuation through a global alarm center network, annual, general, and pre-employment health check-ups, a comprehensive range of vaccination services, health screening services for elderly patients and after-hours clinic visits for emergencies. Together with the Clinics and the Telehealth technologies, Management feels that it will be able to better Diagnose, Educate, and Treat patients.

In 2008, the Central Committee of the Communist Party of China and the State Council, jointly endorsed and issued the Guidelines on Deepening the Reform of the Health-Care System. In spite of the country's economic progress, the development of health care services in many areas has lagged behind. The health-care landscape is much different in China, where health insurance essentially does not exist and there is no established primary care system, people line up in hospital waiting rooms, sometimes for days, to be treated. MDCE's new Telehealth Clinic would target the growing middle class in China who could afford the cost of treatment and address these issues by Educating the general population.

MDCE's new Telehealth Clinic is excited to be working with the local governments as they roll out the government's action plan on health care reform, which will eventually lay a solid foundation for equitable and universal access to essential health care for all in China. Under the 850B Yuan ($124B USD) plan for 2009 to 2011, the government promised universal access to basic health insurance, introduction of an essential drug system, improved primary health care facilities, equitable access to basic public health services and pilot reform of state-run hospitals and med-clinics.

Ning Wu, President of MDCE, stated, "We are at the beginning of this relationship with the health care industry in China. We are committed to providing Telehealth Clinics of the highest standards of care in the cities and rural areas of China. We believe that through our Telehealth Clinics, we have the potential to catalyze progress towards enhanced human health and well-being in China."

About Medical Care Technologies Inc.

Medical Care Technologies Inc. (www.medicaretech.com) is traded under the symbol MDCE on the OTCBB and is based in London, England. The Company is in the process of moving its portfolio of oil resources into medical care technologies. The products/services that the company hopes to acquire are intended to constitute a healthcare delivery and wellness site, dedicated to helping Asian consumers live healthier, more balanced lives. MDCE is planning to provide advanced connectivity, internationally standardized and secure business technology and information systems to assist the Asian health industry -- physicians, pharmacists, medical institutions, and consumers in accessing medical resources, health services, education, wellness and pharmaceutical products throughout Asia. MDCE is planning to distribute and provide services at a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Nutraceuticals. Further information on the Company can be found at www.sec.gov and the company's website at www.medicaretech.com

Safe Harbor Statement

All statements contained in this press release, other than statements of historical fact, are forward-looking statements, including those regarding: MDCE's products, services, capabilities, performance, opportunities, development and business outlook, guidance on our future financial results and other projections or measures of our future performance; the amount and timing of the benefits expected from strategic initiatives and acquisitions or from deployment of new or updated technologies, products, services or applications; and other potential sources of additional revenue. These statements are based on our current plans and expectations and involve risks and uncertainties that could cause actual future events or results to be different than those described in or implied by such forward-looking statements. These risks and uncertainties include those relating to: lack of operating history, transitioning from a development company to an operating company, difficulties in distinguishing MDCE's products and services, ability to deploy MDCE's services and products, market acceptance of our products and services; operational difficulties relating to combining acquired companies and businesses; our ability to form and maintain mutually beneficial relationships with customers and strategic partners; changes in economic, political or regulatory conditions or other trends affecting the healthcare, Internet, information technology and healthcare and pharmaceutical industries, and our ability to attract and retain qualified personnel. Other risks and uncertainties may include, but are not limited to: lack of or delay in market acceptance and fluctuations in customer demand, dependence on a limited number of significant customers, reliance on third party vendors and strategic partners, ability to meet future capital requirements on acceptable terms, continuing uncertainty in the global economy, and compliance with federal and state regulatory requirement. Further information about these matters can be found in our Securities and Exchange Commission filings. We expressly disclaim any intent or obligation to update these forward-looking statements. There can be no assurance that the acquisition of GUC's assets will close. MDCE must issue 57,300,000 shares of its common stock to GUC, or GUC's designees in order to close the acquisition. Accounting for the anticipated cancellation of 57,300,000 shares by Patricia Traczykowski, MDCE will have 98,900,000 shares of its common stock issued and outstanding upon the closing of the acquisition.

Contact Information